Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
92
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Immunic Inc market cap is $102.61M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immunic Inc 52 week high is $17.43 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immunic Inc 52 week low is $5.06 as of November 17, 2026.
Immunic Inc stock price today is $7.23.
Immunic Inc stock price yesterday was $7.52.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Immunic Inc's P/E ratio is -1.62.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Immunic Inc P/B ratio is 1.099.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Immunic Inc 50-day moving average is $8.58.